# Title

 Administrative Personnel. PART 5502â€”SUPPLEMENTAL FINANCIAL DISCLOSURE REQUIREMENTS FOR EMPLOYEES OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES


# ID

 CFR-2018-title5-vol3.Pt. 5502


# Structured Analysis Summary

| Type        | Values                                                |
|:------------|:------------------------------------------------------|
| Constraints | ['maximum', 'before', 'more than', 'within', 'after'] |
| Duration    | ['90.0 day', '30.0 day']                              |
| Entities    | ['Annual', 'Agency', 'Health', 'New', 'Supplemental'] |
| Date        | ['2018-02-28', '2005-08-31', '2005-10-31']            |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                   |
|:--------------|:----------------------------------------------------------------------------------------------------------|
| before        | 5501 of this chapter shall file on or before February 28 of each year a report concerning                 |
| within        | approved pursuant to 5 CFR 5501.106(d) or undertaken within  the reporting period.                        |
| within        | hours spent and leave used on the activity within the reporting period, and the ending date; (e)          |
| after         | and responsibilities of the employee's position that occurred after  the outside activity was approved.   |
| more than     | filing extensions, for good cause shown, totaling not more than  90 days.                                 |
| maximum       | reporting requirement, without regard to the 90 day maximum  specified in paragraph (a) of this section.  |
| within        | A new entrant employee shall report in writing  within 30 days after entering on duty with the            |
| after         | employee shall report in writing within 30 days after entering on duty with the FDA any prohibited        |
| within        | position at the FDA shall report in writing within 30 days of entering on duty with the                   |
| within        | such interest and the value thereof in writing within  30 days after acquiring the financial interest.    |
| after         | the value thereof in writing within 30 days after  acquiring the financial interest.                      |
| within        | as a clinical investigator shall report in writing within 30 days after entering on duty with the         |
| after         | investigator shall report in writing within 30 days after entering on duty with the NIH any financial     |
| within        | position at the NIH shall report in writing within 30 days of entering on duty with the                   |
| within        | such interest and the value thereof in writing within  30 days after acquiring the financial interest.    |
| after         | the value thereof in writing within 30 days after  acquiring the financial interest.                      |
| within        | designated a clinical investigator shall report in writing within 30 days of the approval of the clinical |
| before        | clinical investigator shall report in writing on or before October 31, 2005, any financial interest in a  |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 90.0 day   | These procedures may provide for filing extensions, for good cause shown, totaling not more than 90 days.                                                                                                                                                                                                                                                                                                                                        |
| 90.0 day   | (b) For good cause, the designated agency ethics official may extend the reporting deadlines for reports required under this part during the initial implementation phase for any reporting requirement, without regard to the 90 day maximum specified in paragraph (a) of this section.                                                                                                                                                        |
| 30.0 day   | A new entrant employee shall report in writing within 30 days after entering on duty with the FDA any prohibited financial interest and the value thereof held upon commencement of employment with the agency.                                                                                                                                                                                                                                  |
| 30.0 day   | An employee of a separate agency component other than the FDA or of the remainder of HHS who is reassigned to a position at the FDA shall report in writing within 30 days of entering on duty with the FDA any prohibited financial interest and the value thereof held on the effective date of the reassignment to the agency.                                                                                                                |
| 30.0 day   | An incumbent employee of the FDA who acquires any prohibited financial interest shall report such interest and the value thereof in writing within 30 days after acquiring the financial interest.                                                                                                                                                                                                                                               |
| 30.0 day   | A new entrant employee who is a public filer or a confidential filer or who is designated to serve as a clinical investigator shall report in writing within 30 days after entering on duty with the NIH any financial interest in a substantially affected organization and the value thereof held upon commencement of employment with the agency.                                                                                             |
| 30.0 day   | An employee of a separate agency component, other than the NIH, or of the remainder of HHS who is either a public filer, a confidential filer, or a clinical investigator who is reassigned to a position at the NIH shall report in writing within 30 days of entering on duty with the NIH any financial interest in a substantially affected organization and the value thereof held on the effective date of the reassignment to the agency. |
| 30.0 day   | An incumbent employee of the NIH who is either a public filer, a confidential filer, or a clinical investigator who acquires any financial interest in a substantially affected organization shall report such interest and the value thereof in writing within 30 days after acquiring the financial interest.                                                                                                                                  |
| 30.0 day   | Any incumbent employee, irrespective of financial disclosure filing status, who is designated a clinical investigator shall report in writing within 30 days of the approval of the clinical research protocol by the relevant institutional review board any financial interest in a substantially affected organization and the value thereof held on the date of the IRB approval.                                                            |


## Entities

| Entities     | Context                                                                                                    |
|:-------------|:-----------------------------------------------------------------------------------------------------------|
| Health       | part apply to employees of the Department of Health and Human Services and supplement the Executive Branch |
| Annual       | Annual  supplemental report of outside employment or activities.                                           |
| Agency       | Agency  procedures.                                                                                        |
| Supplemental | Supplemental disclosure of prohibited financial interests applicable to employees                          |
| New          | (c) Report of prohibited financial interests&#8212;(1)  New  entrant employees.                            |
| Supplemental | Supplemental disclosure of financial interests in substantially affected organizations                     |
| Health       | applicable to employees of the National Institutes of Health .                                             |
| New          | Report of financial interests in substantially affected organizations&#8212;(1) New  entrant employees.    |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2018-02-28 | Any employee, other than a special Government employee, for whom an outside employment or activity has been approved, or who has participated in any outside employment or activity for which prior approval is required, under part 5501 of this chapter shall file on or before February 28 of each year a report concerning all such activities that were approved or undertaken in the previous calendar year. |
| 2005-08-31 | An employee on duty at the NIH on August 31, 2005, who is either a public filer, a confidential filer, or a clinical investigator shall report in writing on or before October 31, 2005, any financial interest in a substantially affected organization and the value thereof held on the date the report is filed.                                                                                               |
| 2005-10-31 | An employee on duty at the NIH on August 31, 2005, who is either a public filer, a confidential filer, or a clinical investigator shall report in writing on or before October 31, 2005, any financial interest in a substantially affected organization and the value thereof held on the date the report is filed.                                                                                               |


